Zenith Drugs Limited (NSE:ZENITHDRUG)
India
· Delayed Price · Currency is INR 68.00
-0.90 (-1.31%)
At close: Jun 27, 2025
Zenith Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2018 - 2019 |
Net Income | 95.93 | 48.81 | 31.38 | 30.29 | 34 | Upgrade
|
Depreciation & Amortization | 13.03 | 13.05 | 13.26 | 12.16 | 9.18 | Upgrade
|
Other Amortization | - | - | - | - | 0.01 | Upgrade
|
Other Operating Activities | 28.13 | 22.57 | 20.87 | 15.56 | 12.75 | Upgrade
|
Change in Accounts Receivable | -180.83 | -172.43 | -86.86 | 20.52 | -83.81 | Upgrade
|
Change in Inventory | -20.85 | -115.42 | -52.99 | -24.69 | 5.26 | Upgrade
|
Change in Accounts Payable | -58.38 | 172.87 | 144.18 | -27.39 | 66.62 | Upgrade
|
Change in Other Net Operating Assets | -7.13 | -17.16 | -18.3 | -18.89 | -9.25 | Upgrade
|
Operating Cash Flow | -130.1 | -47.72 | 51.53 | 7.57 | 34.76 | Upgrade
|
Operating Cash Flow Growth | - | - | 580.91% | -78.23% | - | Upgrade
|
Capital Expenditures | -53.3 | -55.71 | -52.42 | -14.28 | -49.3 | Upgrade
|
Sale of Property, Plant & Equipment | 4.85 | 56.77 | - | - | - | Upgrade
|
Investment in Securities | -41.01 | -3.75 | - | - | - | Upgrade
|
Other Investing Activities | 0 | -0 | -0 | - | - | Upgrade
|
Investing Cash Flow | -89.46 | -2.69 | -52.42 | -14.28 | -49.3 | Upgrade
|
Short-Term Debt Issued | - | 85.1 | 10.32 | 57.55 | 4.44 | Upgrade
|
Long-Term Debt Issued | 1.96 | - | 22.96 | - | 22.27 | Upgrade
|
Total Debt Issued | 1.96 | 85.1 | 33.28 | 57.55 | 26.71 | Upgrade
|
Short-Term Debt Repaid | -16.69 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -12.08 | - | -23.48 | - | Upgrade
|
Total Debt Repaid | -16.69 | -12.08 | - | -23.48 | - | Upgrade
|
Net Debt Issued (Repaid) | -14.73 | 73.02 | 33.28 | 34.08 | 26.71 | Upgrade
|
Issuance of Common Stock | 349.5 | - | - | - | - | Upgrade
|
Other Financing Activities | -29.97 | -23.09 | -20.86 | -13.24 | -13.12 | Upgrade
|
Financing Cash Flow | 304.79 | 49.94 | 12.42 | 20.84 | 13.59 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | Upgrade
|
Net Cash Flow | 85.24 | -0.48 | 11.53 | 14.12 | -0.95 | Upgrade
|
Free Cash Flow | -183.4 | -103.43 | -0.89 | -6.72 | -14.54 | Upgrade
|
Free Cash Flow Margin | -13.93% | -9.03% | -0.10% | -0.92% | -1.86% | Upgrade
|
Free Cash Flow Per Share | -10.70 | -8.62 | -0.07 | -0.56 | -1.21 | Upgrade
|
Cash Interest Paid | 20 | 23.09 | 18.18 | 11.46 | 13.12 | Upgrade
|
Cash Income Tax Paid | 40.34 | 18.28 | 13.22 | 13.73 | 15.15 | Upgrade
|
Levered Free Cash Flow | -216.08 | -161.57 | -25.68 | -15.63 | -27.39 | Upgrade
|
Unlevered Free Cash Flow | -203.57 | -154.4 | -14.32 | -8.46 | -19.19 | Upgrade
|
Change in Net Working Capital | 267.19 | 165.49 | 9.57 | 42.67 | 17.38 | Upgrade
|
Updated May 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.